G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 36716693 | Direct conversion of chitin derived N-acetyl-D-glucosamine into 3-acetamido-5-acetylfuran in deep eutectic solvents | Wang K | 2023 Feb |
|
| 36916376 | [O-linked N-acetylglucosamine modification induced by lipopolysaccharide is involved in inflammatory signaling pathway in endothelial cells] | Chen H | 2023 Feb |
|
| 38038745 | Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3 | Zhang Y | 2023 Dec |
|
| 37783244 | Structural insights into the molecular mechanisms of substrate recognition and hydrolysis by feruloyl esterase from Aspergillus sydowii | Phienluphon A | 2023 Dec 31 |
|
| 37739278 | Glycopolymer-grafted nanoparticles as glycosaminoglycan mimics with cell proliferation and anti-tumor metastasis activities | Gu J | 2023 Dec 31 |
|
| 37993332 | Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants | Tan S | 2023 Dec 30 |
|
| 38146215 | Metabolic Usage and Glycan Destinations of GlcNAz in E. coli | Eddenden A | 2023 Dec 26 |
|
| 38096058 | Antigen spacing on protein nanoparticles influences antibody responses to vaccination | Ellis D | 2023 Dec 26 |
|
| 38147266 | Roseomonas populi sp. nov., an acetate-degrading bacteria isolated from the stem of Populus tomentosa | Cheng Y | 2023 Dec 26 |
|
| 38141024 | Structural Insights into the Catalytic Activity of Cyclobacterium marinum N-Acetylglucosamine Deacetylase | Hu S | 2023 Dec 23 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025